BANK VONTOBEL/CALL/BIOGEN IDEC/380/0.1/17.01.25 Stock

Warrant

DE000VM9C0P2

Real-time Boerse Frankfurt Warrants 07:44:36 2024-05-17 am EDT
0.074 EUR +68.18% Intraday chart for BANK VONTOBEL/CALL/BIOGEN IDEC/380/0.1/17.01.25
Current month-10.20%
1 month-30.16%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-17 0.074 +68.18%
24-05-16 0.044 -65.08%
24-05-15 0.126 +50.00%
24-05-14 0.084 +10.53%
24-05-13 0.076 +22.58%

Real-time Boerse Frankfurt Warrants

Last update May 17, 2024 at 07:44 am EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BIOGEN INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM9C0P
ISINDE000VM9C0P2
Date issued 2024-01-30
Strike 380 $
Maturity 2025-01-17 (245 Days)
Parity 10 : 1
Emission price 0.33
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.73
Lowest since issue 0.016
Delta0.04x
Omega 10.66
Premium65.59x
Gearing249.58x
Moneyness 0.6054
Difference Strike 152.7 $
Difference Strike %+40.19%
Spread 0.022
Spread %22.92%
Theoretical value 0.0530
Implied Volatility 28.89 %
Total Loss Probability 98.30 %
Intrinsic value 0.000000
Present value 0.0530
Break even 380.58 €
Theta-0.01x
Vega0.01x
Rho0x

Company Profile

Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (17,2%) ; - other (9,1%): primarily revenues from partnership agreements.
Sector
-
More about the company

Ratings for Biogen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Biogen Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
230 USD
Average target price
285.9 USD
Spread / Average Target
+24.29%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW